UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 923

Sortiert nach

Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors

Gut, 2001-04, Vol.48 (4), p.548-557

2001

Volltextzugriff (PDF)

Is high prevalence of Echinococcus multilocularis in wild and domestic animals associated with disease incidence in humans?

Emerging infectious diseases, 2001-05, Vol.7 (3), p.408-412

2001

Volltextzugriff (PDF)

Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms

The Journal of pharmacology and experimental therapeutics, 2005-06, Vol.313 (3), p.952

2005

Volltextzugriff (PDF)

Vasodilator mRNA levels are increased in the livers of portal hypertensive NO-synthase 3-deficient mice

European journal of clinical investigation, 2004-04, Vol.34 (4), p.283-289

2004

Volltextzugriff (PDF)

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

The New England journal of medicine, 2000-12, Vol.343 (23), p.1666-1672

2000

Volltextzugriff (PDF)

The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver

Journal of hepatology, 1998-06, Vol.28 (6), p.1020-1030

1998

Volltextzugriff (PDF)

Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension

Hepatology (Baltimore, Md.), 1990-06, Vol.11 (6), p.1066-1078

Reichen, JÜRg

1990

Volltextzugriff (PDF)

49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE TRIAL

Journal of hepatology, 2009-04, Vol.50, p.S22-S22

2009

Volltextzugriff (PDF)

Portal hypertension: cytokines and endothelins

Hepato-gastroenterology, 1999-06, Vol.46 Suppl 2, p.1434

Reichen, J

1999

Volltextzugriff (PDF)

The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions

Clinical pharmacology and therapeutics, 2001-04, Vol.69 (4), p.223-231

2001

Volltextzugriff (PDF)

[327] RAS/MEK/ERK AND TGF-BETA/CTGF PATHWAYS AS POSSIBLE DETERMINANTS OF RESISTANCE TO RAPAMYCIN TREATMENT IN BDL-INDUCED LIVER FIBROSIS. RESULTS OF A GENE ARRAY ANALYSIS

Journal of hepatology, 2007, Vol.46, p.S129-S129

2007

Volltextzugriff (PDF)

Quantitative liver tests in living liver donors and their recipients

Liver transplantation, 2006-04, Vol.12 (4), p.514-515

Reichen, Jürg

2006

Volltextzugriff (PDF)

Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats

Biochemical journal, 1991-12, Vol.280 (2), p.373-377

1991

Volltextzugriff (PDF)

Myofibroblasts in the cirrhotic rat liver reflect hepatic remodeling and correlate with fibrosis and sinusoidal capillarization

Journal of hepatology, 1999-04, Vol.30 (4), p.646-652

1999

Volltextzugriff (PDF)

Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis

Annals of the rheumatic diseases, 1994-07, Vol.53 (7), p.475-477

1994

Volltextzugriff (PDF)

False positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate

Molecular pathology, 1998-08, Vol.51 (4), p.204-208

1998

Volltextzugriff (PDF)

Down-regulation of hepatic and renal 11β-hydroxysteroid dehydrogenase in rats with liver cirrhosis

Gastroenterology (New York, N.Y. 1943), 1998, Vol.114 (1), p.175-184

1998

Volltextzugriff (PDF)

Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term

Journal of hepatology, 2006-01, Vol.44 (1), p.167-175

2006

Volltextzugriff (PDF)

Pharmacologic Treatment of Cholestasis

Seminars in liver disease, 1993-08, Vol.13 (3), p.302-315

Reichen, Jürg

1993

Volltextzugriff (PDF)

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis

Gut, 1990-08, Vol.31 (8), p.918-921

1990

Volltextzugriff (PDF)

The Splenoportal Index accurately predicted the presence of oesophageal varices in compensated cirrhosis

Evidence-based medicine (English ed.), 2009-02, Vol.14 (1), p.27-27

Reichen, Jürg

2009

Volltextzugriff (PDF)

Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver

The Journal of clinical investigation, 1986-08, Vol.78 (2), p.448-455

1986

Volltextzugriff (PDF)

Portal hypertension is associated with increased mRNA levels of vasopressor G-protein-coupled receptors in human hepatic arteries

European journal of clinical investigation, 2003-03, Vol.33 (3), p.249-255

2003

Volltextzugriff (PDF)

Cytotoxic T Lymphocytes Derived from Patients with Chronic Hepatitis C Virus Infection Kill Bystander Cells via Fas-FasL Interaction

Journal of Virology, 2004-02, Vol.78 (4), p.2152-2157

2004

Volltextzugriff (PDF)

1 – 25 von 923

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(304)
Mit Volltextzugriff
(870)

Publikationsform

Buchkapitel
(585)
Artikel
(326)
Bücher
(11)
Reviews
(1)

Sprache

Deutsch
(607)
Englisch
(491)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(177)
Life Sciences & Biomedicine
(169)
Male
(148)
Animals
(126)
Biological And Medical Sciences
(124)
Rats
(107)
Humans
(106)
Medical Sciences
(105)
Gastroenterology & Hepatology
(91)
Female
(51)
Gastroenterology. Liver. Pancreas. Abdomen
(49)
Liver - Metabolism
(49)
Adult
(47)
Other Diseases. Semiology
(45)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(44)
Rats, Sprague-Dawley
(43)
Middle Aged
(40)
Rats, Inbred Strains
(36)
Pharmacology. Drug Treatments
(35)
Aged
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors

Is high prevalence of Echinococcus multilocularis in wild and domestic animals associated with disease incidence in humans?

Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Vasodilator mRNA levels are increased in the livers of portal hypertensive NO-synthase 3-deficient mice

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver

Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension

49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE TRIAL

Portal hypertension: cytokines and endothelins

The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions

[327] RAS/MEK/ERK AND TGF-BETA/CTGF PATHWAYS AS POSSIBLE DETERMINANTS OF RESISTANCE TO RAPAMYCIN TREATMENT IN BDL-INDUCED LIVER FIBROSIS. RESULTS OF A GENE ARRAY ANALYSIS

Quantitative liver tests in living liver donors and their recipients

Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats

Myofibroblasts in the cirrhotic rat liver reflect hepatic remodeling and correlate with fibrosis and sinusoidal capillarization

Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis

False positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate

Down-regulation of hepatic and renal 11β-hydroxysteroid dehydrogenase in rats with liver cirrhosis

Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term

Pharmacologic Treatment of Cholestasis

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis

The Splenoportal Index accurately predicted the presence of oesophageal varices in compensated cirrhosis

Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver

Portal hypertension is associated with increased mRNA levels of vasopressor G-protein-coupled receptors in human hepatic arteries

Cytotoxic T Lymphocytes Derived from Patients with Chronic Hepatitis C Virus Infection Kill Bystander Cells via Fas-FasL Interaction

Suchergebnisse filtern